Copied
 
 
Formål
HistorikStartStop
Selskabets formål er at udvikle en APP, hvor kroniske patienter kan optjene stjerner, når de tager deres medicin og anden beslægtet virksomhed i forbindelse hermed samt investering i kapitalandele13.05.201525.09.2023
Virksomheden har ikke ændret Formål i sin levetid.
Ingen nuværende registrering.
Status
HistorikStartStop
OPLØST EFTER KONKURS25.09.202325.09.2023
UNDER KONKURS30.09.202124.09.2023
NORMAL13.05.201529.09.2021
Ingen nuværende registrering.
Branche
HistorikStartStop
Anden udgivelse af software (582900)13.05.201525.09.2023
Virksomheden har ikke ændret Branche i sin levetid.
Ingen nuværende registrering.
Revision
HistorikStartStop
false13.05.201525.09.2023
Virksomheden har ikke ændret Revision i sin levetid.
Ingen nuværende registrering.
Revisor
HistorikStartStop
EY Godkendt Revisionspartnerselskab02.07.201930.09.2021
MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB13.05.201531.07.2019
Ingen nuværende registrering.
Form
HistorikStartStop
8013.05.201525.09.2023
Virksomheden har ikke ændret Form i sin levetid.
Ingen nuværende registrering.
Kontakt
HistorikStartStop
cm@drugstars.com30.09.201625.09.2023
clausmoeldrup@gmail.com13.05.201529.09.2016
Ingen nuværende registrering.
Telefon
HistorikStartStop
2628563630.09.201625.09.2023
Virksomheden har ikke ændret Telefon i sin levetid.
Ingen nuværende registrering.
Navne
Ingen nuværende registrering.
Tegningsregel
HistorikStartStop
Selskabet tegnes af selskabets administrerende direktør og bestyrelsesformanden i forening eller af den samlede bestyrelse.    24.10.201630.09.2021
Selskabet tegnes af ét medlem af direktionen.  13.05.201523.10.2016
Ingen nuværende registrering.
Ansatte
02.10.2024
Kapital
02.10.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these rules and requirements.
Konklusion (revision):We have audited the financial statements of Drugstars ApS for the financial year 1 January - 31 December 2020, which comprise income statement, balance sheet, statement of changes in equity and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2020 and of the results of the Company's operations for the financial year 1 January - 31 December 2020 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
02.10.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
02.10.2024
HistorikStartStop
www.drugstars.com30.09.201625.09.2023
Virksomheden har ikke ændret Hjemmeside i sin levetid.
Ingen nuværende registrering.